-
1
-
-
0017337322
-
Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis
-
J.B. Winfield, I. Faiferman, and D. Koffler Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis J Clin Invest 59 1977 90 96
-
(1977)
J Clin Invest
, vol.59
, pp. 90-96
-
-
Winfield, J.B.1
Faiferman, I.2
Koffler, D.3
-
2
-
-
0025374697
-
Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus
-
E.J. ter Borg, G. Horst, and E.J. Hummel Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus Arthritis Rheum 33 1990 634 643
-
(1990)
Arthritis Rheum
, vol.33
, pp. 634-643
-
-
Ter Borg, E.J.1
Horst, G.2
Hummel, E.J.3
-
3
-
-
0032493059
-
Antibodies to DNA
-
B.H. Hahn Antibodies to DNA N Engl J Med 338 1998 1359 1368
-
(1998)
N Engl J Med
, vol.338
, pp. 1359-1368
-
-
Hahn, B.H.1
-
4
-
-
0025196075
-
Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus
-
M. Schneider, T. Berning, and M. Waldendorf Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus J Rheumatol 17 1990 900 907
-
(1990)
J Rheumatol
, vol.17
, pp. 900-907
-
-
Schneider, M.1
Berning, T.2
Waldendorf, M.3
-
5
-
-
0029980225
-
High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus
-
M. Funauchi, S. Ikoma, and H. Enomoto High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus Intern Med 35 1996 367 372
-
(1996)
Intern Med
, vol.35
, pp. 367-372
-
-
Funauchi, M.1
Ikoma, S.2
Enomoto, H.3
-
6
-
-
0029965906
-
Intravenous immune globulin therapy of lupus nephritis: Use of pathogenic anti-DNA-reactive IgG
-
F. Silvestris, O. D'Amore, and P. Cafforio Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG Clin Exp Immunol 104 1996 91 97
-
(1996)
Clin Exp Immunol
, vol.104
, pp. 91-97
-
-
Silvestris, F.1
D'Amore, O.2
Cafforio, P.3
-
7
-
-
4244086326
-
Updated phase I clinical results with an idiotypic vaccine (3E10) for systemic lupus erythematosus (SLE) [abstract]
-
M.L. Lee, F. Spertini, and A. Leimgruber Updated phase I clinical results with an idiotypic vaccine (3E10) for systemic lupus erythematosus (SLE) [abstract] Arthritis Rheum 8 1995 S303
-
(1995)
Arthritis Rheum
, vol.8
, pp. 303
-
-
Lee, M.L.1
Spertini, F.2
Leimgruber, A.3
-
8
-
-
0033043318
-
Recombinant human DNase I (rhDNase) in patients with lupus nephritis
-
J.C. Davis, S. Manzi, and C. Yarboro Recombinant human DNase I (rhDNase) in patients with lupus nephritis Lupus 8 1999 68 76
-
(1999)
Lupus
, vol.8
, pp. 68-76
-
-
Davis, J.C.1
Manzi, S.2
Yarboro, C.3
-
9
-
-
0029073665
-
Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis
-
D.S. Jones, P.A. Barstad, and M.J. Feild Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis J Med Chem 38 1995 2138 2144
-
(1995)
J Med Chem
, vol.38
, pp. 2138-2144
-
-
Jones, D.S.1
Barstad, P.A.2
Feild, M.J.3
-
10
-
-
0029995138
-
Pharmacologic intervention in antibody mediated disease
-
S.M. Coutts, M.L. Plunkett, and G.M. Iverson Pharmacologic intervention in antibody mediated disease Lupus 5 1996 158 159
-
(1996)
Lupus
, vol.5
, pp. 158-159
-
-
Coutts, S.M.1
Plunkett, M.L.2
Iverson, G.M.3
-
11
-
-
0031055675
-
Reduction in circulating dsDNA antibody titer after administration of LJP 394
-
M.H. Weisman, H.G. Bluestein, and C.M. Berner Reduction in circulating dsDNA antibody titer after administration of LJP 394 J Rheumatol 24 1997 314 318
-
(1997)
J Rheumatol
, vol.24
, pp. 314-318
-
-
Weisman, M.H.1
Bluestein, H.G.2
Berner, C.M.3
-
12
-
-
0037331980
-
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study
-
D. Alarcón-Segovia, J.A. Tumlin, and R.A. Furie LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study Arthritis Rheum 48 2003 442 454
-
(2003)
Arthritis Rheum
, vol.48
, pp. 442-454
-
-
Alarcón-Segovia, D.1
Tumlin, J.A.2
Furie, R.A.3
-
13
-
-
12744275048
-
Abetimus sodium: A new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease
-
M.H. Cardiel Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease Expert Opin Investig Drugs 14 2005 77 88
-
(2005)
Expert Opin Investig Drugs
, vol.14
, pp. 77-88
-
-
Cardiel, M.H.1
-
14
-
-
20244383590
-
Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus
-
M.D. Linnik, J.Z. Hu, and K.R. Heilbrunn Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus Arthritis Rheum 52 2005 1129 1137
-
(2005)
Arthritis Rheum
, vol.52
, pp. 1129-1137
-
-
Linnik, M.D.1
Hu, J.Z.2
Heilbrunn, K.R.3
-
15
-
-
2942703965
-
LJP 394 (abetimus sodium, Riquent®) in the management of systemic lupus erythematosus
-
D.J. Wallace, and J.A. Tumlin LJP 394 (abetimus sodium, Riquent®) in the management of systemic lupus erythematosus Lupus 13 2004 323 327
-
(2004)
Lupus
, vol.13
, pp. 323-327
-
-
Wallace, D.J.1
Tumlin, J.A.2
-
16
-
-
0141849087
-
Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo
-
V. Strand, C. Aranow, and M.H. Cardiel Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo Lupus 12 2003 677 686
-
(2003)
Lupus
, vol.12
, pp. 677-686
-
-
Strand, V.1
Aranow, C.2
Cardiel, M.H.3
|